Regulatory mechanism of mTORC1 activity in pancreatic beta cells in the development of type 2 diabetes
Project/Area Number |
20K08860
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Review Section |
Basic Section 54040:Metabolism and endocrinology-related
|
Research Institution | Kobe University |
Principal Investigator |
|
Project Period (FY) |
2020-04-01 – 2023-03-31
|
Project Status |
Completed (Fiscal Year 2022)
|
Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2022: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2021: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2020: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Keywords | 膵β細胞 / 可塑性 / mTORC1 / 糖尿病 / 膵島 / 脱分化 / 2型糖尿病 |
Outline of Research at the Start |
本研究では、高脂肪食負荷GCN2欠損マウスを用いて以下の解明を目指す。 ・膵β細胞におけるmTORC1活性亢進経路の解明 ・膵β細胞のmTORC1活性調節に及ぼす新規機序の解明 また、ヒトiPS細胞由来の膵β細胞やヒト膵島を用いることによって、EIF2AK4遺伝子のSNP の存在がモデルマウスの結果と合致することを確認する。
|
Outline of Final Research Achievements |
Although the mechanism of pancreatic β-cell volume reduction has not yet been elucidated, mTORC1 activation in islets of type 2 diabetes patients is thought to be involved. In this study, we analyzed pancreatic β-cell-specific TSC2 knockout (βTSC2KO). βTSC2KO showed an increase in chromogranin A-positive and islet hormone-negative cells, suggesting a differentiation effect. βTSC2KO islets showed amylase-positive cells, which were associated with the exocrine cells, and co-positivity of Ptf1a and chromogranin A, a transcription factor of exocrine cells, was also observed. These results suggest that homeostatic activation of mTORC1 may cause a decrease in β-cells by converting them into exocrine cells in old age.
|
Academic Significance and Societal Importance of the Research Achievements |
糖尿病は1型、2型いずれにおいても、膵β細胞量が発症において重要な因子となる。膵β細胞量減少機序については、これまでに多くの報告があるが、いまだに臨床応用されるようなものはない。代表者は糖尿病膵島でmTORC1が活性化されていることに注目し、mTORC1活性調節を制御することが出来れば、1型糖尿病の根治や2型糖尿病の発症予測ができるのではないかと考えた。本研究を進展させることによって、将来的な膵β細胞不全の治療・予防につながるものと期待している。
|
Report
(4 results)
Research Products
(16 results)
-
-
-
[Journal Article] A case of multiple glucagonomas with no clinical manifestations of excess glucagon despite hyperglucagonemia2023
Author(s)
Amano S, Suenaga S, Hamamoto K, Yada S, Tsuyama T, Shinoda S, Tanaka Y, Takemoto Y, Harada E, Tanabe K, Asahara S, Hoshii K, Takami T.
-
Journal Title
DEN Open
Volume: 3
Issue: 1
DOI
Related Report
Peer Reviewed / Open Access
-
-
[Journal Article] Cyb5r3-based mechanism and reversal of secondary failure to sulfonylurea in diabetes2023
Author(s)
Watanabe H, Du W, Son J, Sui L, Asahara SI, Kurland IJ, Kuo T, Kitamoto T, Miyachi Y, de Cabo R, Accili D.
-
Journal Title
Sci Transl Med.
Volume: 15
Issue: 681
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
-
-
-
-
[Journal Article] Oral administration of D-serine prevents the onset and progression of colitis in mice.2021
Author(s)
Takehito Asakawa, Michio Onizawa, Chikako Saito, Rie Hikichi, Daiki Yamada, Ai Minamidate, Tomoaki Mochimaru, Shun-ichiro Asahara, Yoshiaki Kido, Shigeru Oshima, Takashi Nagaishi, Kiichiro Tsuchiya, Hiromasa Ohira, Ryuichi Okamoto, Mamoru Watanabe.
-
Journal Title
Journal of Gastroenterolog.
Volume: 56
Issue: 8
Pages: 732-745
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
[Journal Article] GCN2 regulates pancreatic β-cell mass by sensing intracellular amino acid levels.2020
Author(s)
Kanno A, Asahara SI, Furubayashi A, Masuda K, Yoshitomi R, Suzuki E, Takai T, Kimura-Koyanagi M, Matsuda T, Bartolome A, Hirota Y, Yokoi N, Inaba Y, Inoue H, Matsumoto M, Inoue K, Abe T, Wei FY, Tomizawa K, Ogawa W, Seino S, Kasuga M, Kido Y.
-
Journal Title
JCI Insight.
Volume: 5
Issue: 9
Pages: 128820-128820
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-